Aspergillosis

views updated May 21 2018

Aspergillosis

Definition

Aspergillosis refers to several forms of disease caused by a fungus in the genus Aspergillus. Aspergillosis fungal infections can occur in the ear canal, eyes, nose, sinus cavities, and lungs. In some individuals, the infection can even invade bone and the membranes that enclose the brain and spinal cord (meningitis ).

Description

Aspergillosis is primarily an infection of the lungs caused by the inhalation of airborne spores of the fungus Aspergillus. Spores are the small particles that most fungi use to reproduce. Although virtually everyone is exposed to this fungus in their daily environment, it rarely causes disease. When Aspergillus does cause disease, however, it usually occurs in those individuals with weakened immune systems (immunocompromised) or who have a history of respiratory ailments. Because it does not present distinctive symptoms, aspergillosis is generally thought to be under-diagnosed and underreported. Furthermore, many patients with the more severe forms of aspergillosis tend to have multiple, complex health problems, such as AIDS or a blood disorder like leukemia, which can further complicate diagnosis and treatment.

Once considered particularly rare, the incidence of reported aspergillosis has risen somewhat with the development of more sophisticated methods of diagnosis and advances made in other areas of medicine, such as with the increased use of certain chemotherapeutic and corticosteroid drugs that are extremely useful in treating various types of cancer but that decrease the individual's immune response, making them more susceptible to other diseases like aspergillosis.

Our advanced ability to perform tissue and organ transplants has also increased the number of people vulnerable to fungal infections. Transplant recipients, particularly those receiving bone marrow or heart transplants, are highly susceptible to Aspergillus, which may be circulating in the hospital air.

KEY TERMS

Antibody A specific protein produced by the immune system in response to a specific foreign protein or particle called an antigen.

Aspergilloma A ball or mass made of Aspergillus fungi that can form in the lungs of patients with suppressed immune systems.

Bronchial lavage A procedure that involves repeatedly washing the inside of the bronchial tubes of the lung.

Hemoptysis Spitting up blood from the lungs or sputum stained with blood.

Immunocompromised A state in which the immune system is suppressed or not functioning properly.

Meningitis Inflammation of the membranes covering the brain and spinal cord, called the meninges.

Nebulizer A device that produces an extremely fine mist that is readily inhalable.

Spores The small, thick-walled reproductive structures of fungi.

Sputum Mucus and other matter coughed up from the airways.

Aspergillosis can be a serious, potentially deadly threat for two primary reasons:

  • Aspergillosis usually occurs in those individuals who are already ill or have weakened immune systems, such as patients who have undergone chemotherapy for cancer.
  • None of the currently available antifungal drugs are reliably effective against Aspergillus.

Causes and symptoms

Airborne Aspergillus spores enter the body primarily through inhalation but can also lodge in the ear or eye. Normally functioning immune systems are generally able to cope without consequent development of aspergillosis.

It is important to make distinctions between the various forms of aspergillosis, as the treatment and prognosis varies considerably among types. Aspergillosis as a diagnosis refers to three general forms:

  • Allergic bronchopulmonary aspergillosis (ABPA) is seen in patients with long-standing asthma, particularly in patients taking oral corticosteroids for a long period of time. This is usually the least serious and most treatable form.
  • Aspergilloma refers to the mass formed when fungal spores settle into or colonize areas of the lung that have been pitted and scarred as a result of tuberculosis or prior pneumonia. There are several available treatments, although the success rate varies with each treatment.
  • Invasive fungal infection refers to rare cases in which the fungus spreads throughout the body via the blood stream and invades other organ systems. Once established, invasive fungal infections are extremely difficult to cure and, as a result, the associated death rate is extremely high.

Diagnosis

Aspergillosis can be quite difficult to diagnose because the symptoms, such as coughing and wheezing, if present at all, are common to many respiratory disorders. Furthermore, blood and sputum cultures are not very helpful. The presence of Aspergillus is so common, even in asthmatics, that a positive culture alone is insufficient for a diagnosis. Other, potentially more useful, screening tools include examining the sample obtained after repeatedly washing the bronchial tubes of the lung with water (bronchial lavage), but examining a tissue sample (biopsy) is the most reliable diagnostic tool. Researchers are currently attempting to develop a practical, specific, and rapid blood test that would confirm Aspergillus infection.

Signs of ABPA include a worsening of bronchial asthma accompanied by a low-grade fever. Brown flecks or clumps may be seen in the sputum. Pulmonary function tests may show decreased blood flow, suggesting an obstruction within the lungs. Elevated blood levels of an antibody produced in response to Aspergillus and of certain immune system cells may indicate a specific allergic-type immune system response.

A fungal mass (aspergilloma) in the lung usually does not produce clear symptoms and is generally diagnosed when seen on chest x rays. However, 70% or more of patients spit up blood from the lungs (hemoptysis ) at least once, and this may become repetitive and serious. Hemoptysis, then, is another indication that the patient may be suffering from an aspergilloma.

In patients with lowered immune systems who are at risk for developing invasive aspergillosis, the physician may use a combination of blood culture with visual diagnostic techniques, such as computed tomography scans (CT) and radiography, to arrive at a likely diagnosis.

Treatment

The treatment method selected depends on the form of aspergillosis. ABPA can usually be treated with many of the same drugs used to treat asthma, such as systemic steroids. Long-term therapy may be required, however, to prevent recurrence. Antifungal agents are not recommended in the treatment of ABPA. In cases of aspergilloma, it may become necessary to surgically remove or reduce the size of a fungal mass, especially if the patient continues to spit up blood. In aspergillosis cases affecting the nose and nasal sinuses, surgery may also be required.

In non-ABPA cases, the use of antifungal drugs may be indicated. In such cases, amphotericin B (Fungizone) is the first-line therapy. The prescribed dose will depend on the patient's condition but usually begins with a small test dose and then escalates. Less than one-third of patients are likely to respond to amphotericin B, and its side effects often limit its use. For patients who do not respond to oral amphotericin B, another option is a different formulation of the same drug called liposomal amphotericin B.

For patients who fail to respond or who cannot tolerate amphotericin B, another drug called itraconazole (Sporanox), given 400-600 mg daily, has also been approved. Treatment generally lasts about 3 months. Giving itraconazole can produce adverse reactions if prescribed in combination with certain other drugs by increasing the concentrations of both drugs in the blood and creating a potentially life-threatening situation. Even antacids can significantly affect itraconazole levels. As a result, drug levels must be continually monitored to ensure that absorption is occurring at acceptable levels.

Two other methods of treatment are being studied: direct instillation of an antifungal agent into the lungs and administration of antifungals using a nebulizer. Instilling or injecting amphotericin B or itraconazole directly into the lung cavity or into the fungal ball (aspergilloma) itself has been helpful in stopping episodes of hemoptysis, but not in preventing future recurrences. Furthermore, many patients with aspergillomas are poor risks for surgery because their lung function is already compromised. As a result, instillation of a fungal agent should only be considered in those who have significant hempotysis.

A popular method of treating some respiratory disorders is to add a liquid drug to another carrier liquid and aerosolize or produce a fine mist that can be inhaled into the lungs through a device called a nebulizer. However, this has not yet been shown to improve the patient's condition in cases of aspergillosis, possibly because the drug is not reaching the aspergilloma.

At this point, preventative therapy for aspergillosis is not suggested for susceptible individuals, primarily because overuse of the drugs used to fight fungal infections may lead to the development of drug-resistant aspergillosis against which current antifungal drugs are no longer effective.

Prognosis

The likelihood of recovery from aspergillosis depends on any underlying medical conditions, the patient's general health, and the specific type of aspergillosis. If the problem is based on an allergic response, as in ABPA, the patient will likely respond well to systemic steroids.

Patients who require lung surgery, especially those who have problems with coughing up blood, have a mortality rate of about 7-14%, and complications or recurrence may result in a higher overall death rate. However, by treating aspergilloma with other, non-surgical methods, that risk rises to 26%, making surgery a better option in some cases.

Unfortunately, the prognosis for the most serious form, invasive aspergillosis, is quite poor, largely because these patients have little resilience due to their underlying disorders. Death rates have ranged from about 50% in some studies to as high as 95% for bone-marrow recipients and patients with AIDS. The course of the illness can be rapid, resulting in death within a few months of diagnosis.

Prevention

Fungal infection by Aspergillus presents a major challenge, particularly in the patient with a suppressed immune system (immunocompromised). Hospitals and government health agencies continually seek ways to minimize exposure for hospitalized patients. Practical suggestions are minimal but include moving leaf piles away from the house. Unfortunately, overall avoidance of this fungus is all but impossible because it is present in the environment virtually everywhere. Research efforts are being directed at enhancing patients' resistance to Aspergillus rather than trying to eliminate exposure to the fungus. Given the growing number of people with immune disorders or whose immune systems have been suppressed in the course of treating another disease, research and clinical trials for new antifungal agents will be increasingly important in the future.

Resources

ORGANIZATIONS

American College of Allergy, Asthma, and Immunology. 85 West Algonquin Road, Suite 550, Arlington Heights, IL 60005. http://allergy.mcg.edu.

OTHER

"Lung, Allergic and Immune Diseases: Mold Allergy: Prevention Techniques." National Jewish Medical and Research. http://nationaljewish.org/main.html.

Office of Rare Diseases (ORD) at National Institutes of Health, Bldg. 31,1BO3, Bethesda, MD 20892-2082. (301) 402-4336 http://rarediseases.info.nih.gov/ord.

Aspergillosis

views updated May 23 2018

Aspergillosis

Introduction

Disease History, Characteristics, and Transmission

Scope and Distribution

Treatment and Prevention

Impacts and Issues

BIBLIOGRAPHY

Introduction

Aspergillosis is a lung infection or allergic reaction that is caused by a type of fungus called Aspergillus. The fungus, which is found naturally on decaying organic material such as leaves, hay, and compost, can infect the lungs. Pulmonary aspergillosis can remain confined to the lungs or can spread to other parts of the body. The more widespread infection can be especially serious. It occurs most commonly in people whose immune systems are less capable of fighting off infections.

Disease History, Characteristics, and Transmission

Aspergillosis is most typically caused by Aspergillus fumigatus or A. flavus. Less commonly, the infection is caused by A. terreus, A. nidulans, and A. niger.

Inhalation of the spores of Aspergillus can lead to the growth of the fungus in the lungs. This growth can cause an allergic reaction called pulmonary aspergillosis. The infection, which can develop along with asthma, can diminish the ability of the lungs to function. Growth of the fungus also can produce a compact structure called a fungus ball. The ball tends to develop in an area of the lung that has previously been damaged by tuberculosis or some other infection that results in a localized buildup of fluid or infected material.

Pulmonary aspergillosis also can be more invasive, meaning the infection can move from the lungs to other parts of the body. This spread is promoted when the infection is less efficiently cleared due to a compromised immune system, as can occur during treatment for cancer and some other ailments, following organ transplantation to minimize rejection of the transplant, and in people with acquired immunodeficiency syndrome (AIDS, also cited as acquired immune deficiency syndrome).

The symptoms of aspergillosis include fever, a general feeling of tiredness, cough that can be combined with expelled blood or mucous, wheeziness when breathing, loss of weight, and periodic difficulty in breathing. Additional symptoms can be present in the more invasive type of aspergillosis. These include chills, headaches, chest pain, increased amount of expelled mucous, decreased amount of urine, bloody urine, bone pain, inflammation of nerve lining in the brain or spinal cord (meningitis), sinus infection, diminished vision, and heart trouble.

Scope and Distribution

Aspergillosis is global in scope because the fungus that causes the disease is a common environmental organism. The prevalence of aspergillosis is unclear, however, it tends to be more prevalent in areas where the population includes more immunosuppressed people. For example, the city of San Francisco, which has a higher proportion of people with AIDS than some other metropolitan areas, may have a rate of aspergillosis of 1–2 people per 100,000 every year, according to data from the United States Centers for Disease Control and Prevention (CDC).

WORDS TO KNOW

IMMUNOCOMPROMISED: A reduction of the ability of the immune system to recognize and respond to the presence of foreign material.

OPPORTUNISTIC INFECTION: An opportunistic infection is so named because it occurs in people whose immune systems are diminished or are not functioning normally; such infections are opportunistic insofar as the infectious agents take advantage of their hosts’ compromised immune systems and invade to cause disease.

PULMONARY: Having to do with the lungs or respiratory system. The pulmonary circulatory system delivers deoxygenated blood from the right ventricle of the heart to the lungs, and returns oxygenated blood from the lungs to the left atrium of the heart. At its most minute level, the alveolar capillary bed, the pulmonary circulatory system is the principle point of gas exchange between blood and air that moves in and out of the lungs during respiration.

IN CONTEXT: SELECTIVE SURVEILLANCE

In the United States, there currently is no dedicated national surveillance program to track aspergillosis. However, some hospitals do monitor patients who receive transplants of stem cells and organs, because these patients are at higher risk for the infection.

Treatment and Prevention

Aspergillosis is diagnosed by the detection of the lung infection. The infection can be imaged using x-ray or a technique called computed tomography (or CT). The fungus also can be obtained from a sample of expelled mucous or sputum and grown on various food sources. The food sources can be selected to help distinguish one type of fungus from another, and so can help identify the fungus as being from the genus Aspergillus. In addition, the sputum can be stained and examined using a light microscope to detect fungal cells. The staining method produces a less precise result; it reveals the presence of fungi, but is not refined enough to distinguish one genus of fungus from another. However, just knowing that the infection is caused by a fungus can be enough to initiate treatment.

Aspergillosis can also be diagnosed by detecting the presence of protein components of the fungus. The proteins function as antigens and stimulate the production of specific antibodies by the immune system. Aspergillus antigens can be detected by a skin-based reaction, or in a test tube or well of a plastic assay dish by the formation of a cloudy precipitate that is comprised of a complex (product) formed between a specific antigen and antibody.

Treatment for aspergillosis varies depending on the nature of the infection. When the infection involves a fungal ball, treatment can be withheld if the infection is not associated with bleeding into the lung. Then surgery is performed to remove the fungal mass. Aspergillosis that has spread more widely is treated for several weeks with an antifungal agent such as amphotericin B. Treatment is usually done intravenously to maintain a constant and effective level of drug in the body. Aspergillus-infected heart valves are usually removed, and extended treatment with an antifungal drug follows the surgery.

People whose illness is due to an allergic reaction to Aspergillosis do not benefit from the use of an antifungal drug. For them, treatment with prednisone, which dampens the immune system and so reduces the allergic reaction, is the typical approach.

Treatment of aspergillosis carries a risk. Extended use of amphotericin B can harm the kidneys. Use of the drug is a balance of the benefit obtained versus the risk imposed.

Impacts and Issues

The invasive form of aspergillosis can be life threatening. The seriousness of the infection is especially pronounced in people with a malfunctioning immune system. This includes the millions of people around the world who are afflicted with acquired immunodeficiency syndrome (AIDS, also cited as acquired immune deficiency syndrome) and are vulnerable to opportunistic infections. Aspergillosis is yet another danger that confronts someone with AIDS. The death rate from the invasive form of aspergillosis is at least 50%.

Other issues that affect aspergillosis are the lack of a rapid test for the infection, and a lack of knowledge of risk factors that might be modified so as to reduce the risk of the infection. In the United States, research is underway in these areas specifically.

In addition to humans, aspergillosis can affect other species. For example, waterfowl populations can be decimated by aspergillosis outbreaks if the birds feed on decaying grain. Aspergillosis is a common and lethal infection in birds, such as parakeets and parrots.

See AlsoMycotic Disease; Nosocomial (Healthcare-Associated) Infections; Opportunistic Infection.

BIBLIOGRAPHY

Books

Black, Jacquelyn. Microbiology: Principles and Explorations. New York: John Wiley & Sons, 2004.

DiClaudio, Dennis. The Hypochondriac's Pocket Guide to Horrible Diseases You Probably Already Have. New York: Bloomsbury, 2005.

Mader, Sylvia S. Biology. 8th ed. New York: McGraw-Hill, 2003.

Web Sites

Centers for Disease Control and Prevention. “Aspergillosis.” <http://www.cdc.gov/ncidod/dbmd/diseaseinfo/aspergillosis_t.htm> (accessed March 25, 2007).

Brian Hoyle

aspergillosis

views updated Jun 11 2018

aspergillosis (ass-per-jil-oh-sis) n. a group of conditions caused by fungi of the genus Aspergillus, usually Aspergillus fumigatus. These conditions nearly always arise in patients with pre-existing lung disease and fall into three categories. The allergic form most commonly affects asthmatic patients and may cause collapse of segments or lobes of a lung. The colonizing form leads to formation of a fungus ball (aspergilloma), usually within a pre-existing cavity in the lung. In the third form the fungus spreads throughout the lungs and may even disseminate throughout the body; this form is rare but potentially fatal.

aspergillosis

views updated May 29 2018

aspergillosis A general term for any human or animal disease caused by a fungus of the genus Aspergillus. In humans the most common form of the disease is a lung infection which may lead to pneumonia; the disease is uncommon.

aspergillosis

views updated Jun 11 2018

aspergillosis A general term for any human or animal disease caused by a fungus of the genus Aspergillus. In humans the most common form of the disease is a lung infection which may lead to pneumonia; the disease is uncommon.